Radiomics and artificial intelligence-based prediction of tumor response in digestive system neoplasm: a systematic review and meta-analysis
Quick Take: Radiomics and AI hold future promise for predicting tumor response in digestive system cancers, but require rigorous validation before clinical integration.
💡 Clinical Impact
- Offers a potential pathway for earlier, more personalized treatment adaptation in digestive system malignancies.
- Could spare patients from ineffective therapies and guide prognostication more precisely.
📊 Evidence Breakdown
- Evidence Grade: 7/10
- Analysis: This systematic review and meta-analysis synthesizes current data, suggesting AI and radiomics can identify early markers of treatment response in digestive system cancers. However, heterogeneous methodologies and limited prospective validation across studies necessitate caution in interpretation.
🩺 Practice Recommendation
Experimental—Do not integrate into routine clinical decision-making for treatment response prediction currently.